Skip to main content

Focus Partners Wealth

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1542153 ST LOUIS, MO

Position in HALO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$12,760,827
+$1,819,873 QoQ
Shares Held
163,036
-3.7% QoQ
Ownership
0.144%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#105
of 664 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 58% Shared 0% None 42%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Focus Partners Wealth holds $223,178,682 across 77 Biotechnology names. HALO ranks #5 (5.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 HALO
Halozyme Therapeutics, Inc.
This page
163,036 $12,760,827

All Filings in HALO

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,760,827 163,036
2026-03-31 $10,940,954 169,286
2025-12-31 $8,338,402 123,899
2025-09-30 $9,027,640 123,093
2025-06-30 $6,900,088 132,643
2025-03-31 $7,709,205 120,815
2024-12-31 $3,660,094 76,555
2024-09-30 $4,550,923 79,506
2024-06-30 $4,851,311 92,653
2024-03-31 $3,715,914 91,345
2023-12-31 $2,949,149 79,793